MS
Meghna Saxena; Meghna Shrivastava
Research areas: Medicine · Oncology · Glioma Diagnosis and Treatment · Chromatin Remodeling and Cancer · Cancer Immunotherapy and Biomarkers
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- Herbal drugs an alternative medicine for the treatment of neurodegenerative diseases: Preclinical and clinical trial review Save
- IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response Save
- Synaptic plasticity in autism spectrum disorders Save
- EPIGENETIC REPROGRAMMING IN MUTANT IDH1 GLIOMA IMPACTS MEDIAN SURVIVAL, ENHANCES DNA DAMAGE RESPONSE AND CONFERS RADIO-RESISTANCE Save
- Fyn, AN ONCOGENE THAT REDUCES GLIOBLASTOMA SURVIVAL YET SENSITIZES TO CHEMO-RADIOTHERAPY Save
- GENERATION OF A MOUSE MODEL OF DIFFUSE INTRINSIC PONTINE GLIOMA HARBORING ACVR1 G328V AND H3.1 K27M MUTATIONS Save
- Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy Save
- IN VIVO EXPRESSION OF MUTATED IDH1 (R132H) GENE IN A MOUSE MODEL OF YOUNG ADULT GLIOBLASTOMA HAS IMPACT IN MEDIAN SURVIVAL, DNA-REPAIR PATHWAYS, AUTOPHAGY AND OLIGODENDROCYTE DIFFERENTIATION Save
- USING THE SLEEPING BEAUTY TRANSPOSASE SYSTEM TO GENERATE MOUSE MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA HARBORING ACVR1 AND H3K27M MUTATIONS Save
- Poly I:C induced microglial activation impairs motor activity in adult rats Save
- Poly I:C induced microglial activation impairs motor activity in adult rats Save
- Changes in pain sensitivity with age, differ in male and female wistar rats, Rattus norvegicus (Berkenhout) Save
- Changes in pain sensitivity with age,differ in male and female wistar rats, Rattus norvegicus (Berkenhout) Save
- S100β upregulation: A possible mechanism of deltamethrin toxicity and motor coordination deficits Save
- Targeting H3K27-Altered Diffuse Midline Glioma with Combined MEK and HDAC Inhibition: Clinical Response and in Vitro Validation Save